BNET Industries
Market Cap:$304.6M
Last Fiscal Year Sales:$264.6M
- Public
Dow Jones Description
Nutraceutical & Pharmaceutical Products Developer & Distr
Chairman & CEO
Tony LiuNumber of Employees 4,076
Contact Information
25th Floor Great China International Exchange Square
Shenzhen 518034
(86) 451 8666 6601
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
American Oriental's Q3 Disappoints Again
-
12 small stocks survive screen, worth a look
-
American Oriental Bioengineering Inc unveils YYQH capsules for throat inflammation
-
7 Highly Rated Stocks on Sale
-
American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
News & Analysis
Filter by
american oriental bioengineering inc. and chinabio today - All News and Analysis
American Oriental's Q3 Disappoints Again
ChinaBio Today submits: American Oriental Bioengineering (NYSE: AOB) reported its Q3 revenues rose 12% to $78.8 million but net income fell 39% to $10.0 million. Though the company had a list of reasons for the decline, the mixed nature of American Oriental’s financial disclosures – higher revenues and lower...
American Oriental Adds Laryngitis Product to Portfolio
ChinaBio Today submits: American Oriental Bioengineering (NYSE: AOB) is adding a new laryngitis product to its portfolio of OTC traditional Chinese medicine offerings. YuYeQingHuo Capsules (YYQH) are used to alleviate pain and inflammation related to laryngitis, acute pharyngitis and acute aphonia. They will be manufactured by American Oriental’s Boke...
American Oriental Reports Approval for 61 Essential Drug List Products
ChinaBio Today submits: American Oriental Bioengineering (NYSE: AOB) reported it has SFDA approval to produce 61 of the products included in China's newly announced Essential Drug List, though the company is currently producing only six of them. American Oriental markets 60 pharmaceutical products, and it has another 400 products...
American Oriental Reports Mixed Q2
ChinaBio Today submits: American Oriental Bioengineering, Inc. (NYSE: AOB) reported higher Q2 revenues, though the company’s improved sales did not translate to the bottom line. American Oriental’s revenues rose 21% in the period to $71.2 million, but net income slipped 5% lower to $13.2 million. Earnings per fully diluted...
American Oriental Makes China's Top 20 Pharmas List, Aims for Top Five
ChinaBio Today submits: American Oriental Bioengineering, Inc. (NYSE: AOB) was selected as one of the "Top 20 Most Competitive Public Pharmaceutical Companies in China." The honor came after American Oriental was chosen from 132 China public pharmaceutical companies whose shares are traded on exchanges in China, the US or...
American Oriental Reports Higher Revenues, Lower Profit in Q1
ChinaBio Today submits: American Oriental Bioengineering (NYSE: AOB) reported mixed results for its first quarter. Revenue increased 19% from the year-earlier quarter to $46.1 million, but net income fell 16% to $7.9 million. American Oriental commented that $1.7 million in interest expense for newly issued convertible bonds was the...
American Oriental Investors Remain Wary Despite Impressive Q4
ChinaBio Today submits: American Oriental Bioengineering, Inc. (NYSE: AOB) continued to perform well financially in 2008, even though its corporate business developments sometimes confuse and frustrate investors. The company said 2008 revenues were up 65% to $264.6 million. Non-GAAP net income rose 45% to $62.7 million. Both numbers show...
American Oriental Bioengineering Keeps Growing Despite Bad Moves
ChinaBio Today submits: American Oriental Bioengineering (NYSE: AOB) found itself, once again, defending one of management’s initiatives. Last week, AOB said it had closed a $70 million purchase of buildings and land in Beijing. Unfortunately for AOB, the release said the site and its facilities would be used as...
American Oriental Books Another Solid Quarter
ChinaBio Today submits: American Oriental Bioengineering AOB announced another solid financial performance in Q3. The company’s revenues rose 62% to $70.6 million, and net income was higher by 38% at $16.5 million or 21 cents per diluted share. According to the company, net income failed to keep pace with...
American Oriental Announces Two Acquisitions
ChinaBio Today submits: American Oriental Bioengineering, Inc. AOB completed two acquisitions while, at the same time, announcing it had declined to pursue a third. In August, AOB had announced a signed letter of intent to pay $110 million to acquire an unnamed China pharmaceutical distributor with $550 million in...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Binsheng Li | Chief Accounting Officer |
| Yanchun Li | Cfo, Coo & Secretary |
| Jun Min | Vice President |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Tony Liu | Chairman & CEO |
| Baiqing Zhang | Board of Directors |
| Cosimo J. Patti | Board of Directors |
| Eileen Brody | Board of Directors |
| Lawrence S. Wizel | Board of Directors |
| Shunjun Liu | Board of Directors |
| Xianmin Wang | Board of Directors |
| Xianmix Wang | Board of Directors |
Tony Liu is the principal founder of our Company and has served as our Chief Executive Officer and the Chairman of our Board of Directors since 2001. He served in the army for over 19 years. After Mr. Liu left the army, he began working for the government in the Heilongjiang province in northeastern China. In addition to serving as a representative to the National People’s Congress in China, with his practical work experience in the Chinese community for many years, Mr. Liu has witnessed and participated in the massive macro economic changes for the past thirty years. He has many years of experience in managing the army, government agencies and pharmaceutical companies. Mr. Liu was named the Outstanding Chinese Entrepreneur of the World and he is currently the Vice Chairman of the World Eminence Chinesebusiness Association. Mr. Liu graduated with a major in Communications & Commands from WuhanCommunicationCollege in 1986 and studied Integrated Marketing and Media at the University of Hong Kong in 2004. He received EMBA degree at PrestonUniversity in 2005.Mr. Liu studied in the Program of Sustainable Growth of Large Corporations sponsored by the School of Engineering and the School of Business at StanfordUniversity. He is studying for DBA degree at Silicon ValleyUniversity.
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Chairman & CEO | Current |
Binsheng Li is one of our partner founders and has served as our Chief Accounting Officer and as a member of our Board of Directors since 2002. Mr. Li began his career at Three-Happiness Bioengineering, Co. Ltd. in 1994 in the accounting department. Mr. Li is in charge of all financial management and accounting work for the Company. Mr. Li graduated from DalianFinancialSchool in 1986 with a major in Finance and Economics.
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Chief Accounting Officer | Current |
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
Yanchun Li is one of our partner founders and has served as Chief Financial Officer since May 2007. Prior to her appointment as Chief Financial Officer, she had been the Acting Chief Financial Officer since May 2002, Chief Operating Officer and Secretary since October 2003 and has worked at the Company and served as a member of the Board since 2002. Ms. Li has fifteen years of experience in management in the food industry and the pharmaceutical industry in China. In particular, she has extensive experience and innovative insight in marketing, management, brand building, corporate strategy, human resource and financial capital management. Before joining us, Ms. Li worked for China Ruida Food Limited Company and successfully established the Ruida brand as the number one brand in the instant frozen food industry. Ms. Li joined Three-Happiness Bioengineering, Co. Ltd. in 1994 and was in charge of the marketing and sales. Under her leadership, the functional drinks of the Three-Happiness brand has reached stunning achievement nationwide across China. The Three-Happiness brand was later awarded the Top Ten Well-known Brands in China. Ms. Li won the China Golden Award in Marketing of Year 2005 and was elected into the Who is Who of Chinese Origin Worldwide. Ms. Li received her BA in English from Beijing University of Industry and Commerce in 1993 and completed the Owner/President Management Program in 2008, an advanced program, at HarvardBusinessSchool.
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Cfo, Coo & Secretary | Current |
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
Jun Min is one of our partner founders and has served as our Vice President and as a member of our Board of Directors since 2002. Mr. Min worked at the Price Checking Department Bureau of Heilongjiang Province from 1987 to 1992. Subsequently, he worked for Three- Happiness Bioengineering, Co. Ltd. from 1994. He has over 20 years of experience in operations management and has an extensive knowledge of the consumer and pharmaceutical products industries in China. Mr. Min received a BA in Business Management from HarbinBroadcast & TVUniversity in 1986. He received EMBA from PrestonUniversity in 2005.
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Vice President | Current |
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
Baiqing Zhang has served on our Board of Directors since 2006. Mr. Zhang brings to us two decades of experience in the Chinese government¡¯s regulatory and supervisory divisions. From 1997 until Mr. Zhang retired in 2005, Mr. Zhang served as Deputy Director, Division Chief of the Heilongjiang Regulatory Bureau of the China Securities Regulatory Commission, or CSRC, where he managed and imposed regulatory compliance for all Heilongjiang-based securities issuances, as well as supervised securities trading, investment funds and legal affairs. The CSRC is China’s primary regulatory body overseeing the country’s financial markets. Prior to this, he spent ten years as a member of the Discipline Inspection Committee in the Department of Supervision of the HeilongjiangProvince, and previously was the Vice Principal of Hebei Institute of Mechanical and Electrical Technology, where he taught college courses. Since 2005, Mr. Zhang has been a consultant in the fields of law and economics, public policy, and business strategy. He also consults and lectures about regulatory issues in the Chinese securities markets, based on his significant experience at the CSRC. Mr. Zhang received a degree in Management of Economics from the TianjinNormalUniversity and a degree in Accounting from the HeilongjiangEconomicsManagementAcademy.
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
Cosimo Patti has served on our Board of Directors since 2004. Before joining us, Mr. Patti was an arbitrator for the National Association of Securities Dealers and the New York Stock Exchange for 18 years. Since August 1999, Mr. Patti has been the President and Chairman of Technology Integration Group, Inc. In June 2007, Mr. Patti joined the board of directors of Advanced Battery Technologies, Inc. (NASDAQ:ABAT), a company engaged in the business of designing, manufacturing and marketing rechargeable polymer lithium-ion batteries. From 2002 to 2004, Mr. Patti was the Senior Director of Applications Planning with iCi/ADP. He was the Director of Strategic Cross-border Business with Cedel Bank from 1996 to 1999, and President and Founder of FSI Advisors Group from 1998 to 2002. Mr. Patti attended BrooklynCollege from 1968 to 1970.
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
| Lehman Brothers Holdings Inc. | Senior Vice President, compliance officer | Former |
| Lehman Brothers Holdings Inc. | Strategic director | Former |
Eileen Brody has served on our Board of Directors since 2005. Since August 2005, Ms. Brody has been President of Dawson-Forte Cashmere, an apparel trading company. Since June 2007 Ms. Brody has been a member of the board of directors of Fuqi International, Inc. (NASDAQ:FUQI), a company specializing in designing, developing, promoting, and selling a range of precious metal jewelry products in the Chinese luxury goods market. From 1997 to 2004, she was Vice President of Merchandising and Planning for Carter¡¯s Retail division of The William Carter Company. From 1992 to 1997, she held various management positions for Melville Corporation, a multi-billion dollar retailer. From 1983 to 1990, Ms. Brody worked for KPMG Peat Marwick as a Senior Manager. Ms. Brody is a Certified Public Accountant. She received her Undergraduate and MBA degrees from PaceUniversity and a second MBA from the Harvard Graduate School of Business.
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
Lawrence Wizel has served on our Board of Directors since 2006. Prior to joining our Board of Directors, he served as Deputy Professional Practice Director at Deloitte Touche USA LLP, or Deloitte, in Deloitte’s New York office. Mr. Wizel began his career at Deloitte in 1965 and was a partner from 1980 until he retired in June 2006. Mr. Wizel was responsible for serving a diverse client base of publicly held and private companies in a variety of capacities including, SEC filings, initial public offerings, mergers and acquisition transactions and periodic reporting. Since September 2006, Mr. Wizel has been a member of the board of directors of 3SBio Inc. (NASDAQ:SSRX), a biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Since August 2007, Mr. Wizel has been a member of the board of directors of Puda Coal, Inc. (OTC:PUDC), a supplier of metallurgical coking coal to the industrial sector in China. He received his BA in 1965 in accounting from MichiganStateUniversity and is a Certified Public Accountant.
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
| American Oriental Bioengineering, Inc. | CEO | Former |
Xianmin Wang has served on our Board of Directors since 2005. He was the Vice Governor of Heilongjiang Province from 1998 to 2003, where he was in charge of Financial and Economic affairs. Mr. Wang was Secretary of Daqing Municipal Party Committee from 1996 to 1998, and Vice Secretary of Harbin Municipal Party Committee from 1991 to 1992. Mr. Wang received a post graduate degree in Philosophy from Renmin University of China in 1964. He also holds a bachelor’s degree in Economics from NortheastForestUniversity and postgraduate degrees in Philosophy from HeilongjiangUniversity and Renmin University of China.
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| American Oriental Bioengineering, Inc. | Board of Directors | Current |
Executive News
-
AOBO's Products Included in China's Essential Drug List
-
AOBO's Products Included in China's Essential Drug List
-
American Oriental Bioengineering's 'Jinji Capsules' and 'Boke Nasal Spray' Designated...
-
American Oriental Bioengineering's 'Jinji Capsules' and 'Boke Nasal Spray' Designated Among 'China's Top Branded Drugs of 2009'
-
AOBO Announces New Product Launch
-
American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
| Volume | 364,339 |
| Shares Outstanding | 78.3M |
| Market Cap | 304.6M |
| Year High | 7.66 |
| Year Low | 3.29 |
| Earnings Per Share | 0.51 |
| P/E Ratio | 7.6275 |
| Dividend | 0.00 |
| Yield | 0.00 |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes


